Correlation Between Mereo Biopharma and US Bancorp

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Mereo Biopharma and US Bancorp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mereo Biopharma and US Bancorp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mereo Biopharma Group and US Bancorp, you can compare the effects of market volatilities on Mereo Biopharma and US Bancorp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mereo Biopharma with a short position of US Bancorp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mereo Biopharma and US Bancorp.

Diversification Opportunities for Mereo Biopharma and US Bancorp

-0.66
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Mereo and US Bancorp is -0.66. Overlapping area represents the amount of risk that can be diversified away by holding Mereo Biopharma Group and US Bancorp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on US Bancorp and Mereo Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mereo Biopharma Group are associated (or correlated) with US Bancorp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of US Bancorp has no effect on the direction of Mereo Biopharma i.e., Mereo Biopharma and US Bancorp go up and down completely randomly.

Pair Corralation between Mereo Biopharma and US Bancorp

Given the investment horizon of 90 days Mereo Biopharma is expected to generate 5.93 times less return on investment than US Bancorp. In addition to that, Mereo Biopharma is 3.61 times more volatile than US Bancorp. It trades about 0.0 of its total potential returns per unit of risk. US Bancorp is currently generating about 0.05 per unit of volatility. If you would invest  3,428  in US Bancorp on May 14, 2022 and sell it today you would earn a total of  1,416  from holding US Bancorp or generate 41.31% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy99.8%
ValuesDaily Returns

Mereo Biopharma Group  vs.  US Bancorp

 Performance (%) 
       Timeline  
Mereo Biopharma Group 
Mereo Performance
15 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Mereo Biopharma Group are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite quite conflicting technical and fundamental indicators, Mereo Biopharma disclosed solid returns over the last few months and may actually be approaching a breakup point.

Mereo Price Channel

US Bancorp 
US Bancorp Performance
1 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in US Bancorp are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, US Bancorp is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

US Bancorp Price Channel

Mereo Biopharma and US Bancorp Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Mereo Biopharma and US Bancorp

The main advantage of trading using opposite Mereo Biopharma and US Bancorp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mereo Biopharma position performs unexpectedly, US Bancorp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in US Bancorp will offset losses from the drop in US Bancorp's long position.

Mereo Biopharma Group

Pair trading matchups for Mereo Biopharma

The idea behind Mereo Biopharma Group and US Bancorp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Complementary Tools

ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go